The Egyptian Journal of Bronchology

Table 1 Demographic data, risk factors, and comorbidities of the studied patients

From: Prognostic value of echocardiographic indices in risk stratification of intermediate-risk pulmonary embolism

	Group I (n = 32)	Group II (n= 28)	P value
Demographic data
Age (years)^a	45.65 ± 16.50	51.14 ± 15.33	0.19
Sex, %			0.18
Male	15 (46.9%)	9 (32.1%)
Female	17 (53.1%)	19 (67.9%)
Smoking	4 (12.5%)	4 (14.3%)	0.65
Risk factors, %
Contraceptive pills	5 (15.6%)	3 (10.7%)	0.43
Lower limb Fracture	4 (12.5%)	6 (21.4%)	0.28
DVT	5 (15.6%)	6 (21.4%)	0.40
Previous PE	2 (6.3%)	2 (6.3%)	0.64
Previous CS	0	2 (7.1%)	0.21
Post-COVID19	2 (6.3%)	2 (7.1%)	0.64
Comorbidities, %
Diabetes mellitus	5 (15.6%)	4 (14.3%)	0.58
Hypertension	2 (6.3%)	2 (7.1%)	0.64
Cardiac diseases	1 (3.1%)	0	0.53
Malignancy	0	2 (7.1%)	0.21
COPD	1 (3.1%)	0	0.53
OHS	1 (3.1%)	0	0.53
Bronchiectasis	1 (3.1%)	1 (3.6%)	0.72
SLE	0	1 (3.6%)	0.46

Data expressed as frequency (%). mean (SD)^a. P value was significant if < 0.05. COPD, chronic obstructive pulmonary disease; CS, cesarean section; DVT, deep venous thrombosis; OHS, obesity hypoventilation syndrome; PE, pulmonary embolism; SLE, systemic lupus erythematosus

Back to article page